Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: an animal study.

Li CL, He J, Li ZG, Zheng LW, Hua H.

J Craniomaxillofac Surg. 2013 Oct;41(7):610-5. doi: 10.1016/j.jcms.2012.11.042. Epub 2013 Jan 18.

PMID:
23333492
[PubMed - indexed for MEDLINE]
2.

[Clinical observation on effect of total glucosides of paeony in treating patients with non-systemic involved Sjögren syndrome].

Zhang HF, Hou P, Xiao WG.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Jul;27(7):596-8. Chinese.

PMID:
17717915
[PubMed - indexed for MEDLINE]
3.

[Study on total glucosides of peony preventing non-obese diabetic mice from sialoadenitis].

Li CL, He J, Hua H.

Hua Xi Kou Qiang Yi Xue Za Zhi. 2011 Apr;29(2):187-90. Chinese.

PMID:
21598496
[PubMed - in process]
Free Article
4.

Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis?

van Blokland SC, van Helden-Meeuwsen CG, Wierenga-Wolf AF, Drexhage HA, Hooijkaas H, van de Merwe JP, Versnel MA.

Lab Invest. 2000 Apr;80(4):575-85.

PMID:
10780673
[PubMed - indexed for MEDLINE]
5.

NOD mouse model for Sjögren's syndrome: lack of longitudinal stability.

Lodde BM, Mineshiba F, Kok MR, Wang J, Zheng C, Schmidt M, Cotrim AP, Kriete M, Tak PP, Baum BJ.

Oral Dis. 2006 Nov;12(6):566-72.

PMID:
17054769
[PubMed - indexed for MEDLINE]
6.

Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease.

Gillespie K, Kodani I, Dickinson DP, Ogbureke KU, Camba AM, Wu M, Looney S, Chu TC, Qin H, Bisch F, Sharawy M, Schuster GS, Hsu SD.

Life Sci. 2008 Oct 24;83(17-18):581-8. doi: 10.1016/j.lfs.2008.08.011. Epub 2008 Sep 6.

PMID:
18809413
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Apoptosis and apoptosis-related molecules in the submandibular gland of the nonobese diabetic mouse model for Sjögren's syndrome: limited role for apoptosis in the development of sialoadenitis.

Van Blokland SC, Van Helden-Meeuwsen CG, Wierenga-Wolf AF, Tielemans D, Drexhage HA, Van De Merwe JP, Homo-Delarche F, Versnel MA.

Lab Invest. 2003 Jan;83(1):3-11.

PMID:
12533681
[PubMed - indexed for MEDLINE]
8.

Assessment of bromhexine as a treatment regimen in Sjögren's syndrome-like disease in the NOD (non-obese diabetic) mouse.

Nanni JM, Nguyen KH, Alford CE, Robinson CP, Stewart CM, Maeda N, Humphreys-Beher MG.

Clin Exp Rheumatol. 1997 Sep-Oct;15(5):515-21.

PMID:
9307859
[PubMed - indexed for MEDLINE]
9.

Effects of Ganoderma lucidum spores on sialoadenitis of nonobese diabetic mice.

Qi G, Hua H, Gao Y, Lin Q, Yu GY.

Chin Med J (Engl). 2009 Mar 5;122(5):556-60.

PMID:
19323907
[PubMed - indexed for MEDLINE]
Free Article
10.

P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome.

Schrader AM, Camden JM, Weisman GA.

Arch Oral Biol. 2005 Jun;50(6):533-40. Epub 2004 Dec 15.

PMID:
15848146
[PubMed - indexed for MEDLINE]
11.

Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice.

Li N, Shigihara T, Tzioufas AG, Notkins AL, Yoon JW, Jun HS.

Arthritis Rheum. 2007 Jul;56(7):2211-5.

PMID:
17599739
[PubMed - indexed for MEDLINE]
Free Article
12.

Local suppression of IL-21 in submandibular glands retards the development of Sjögren's syndrome in non-obese diabetic mice.

Liu H, Liu G, Gong L, Zhang Y, Jiang G.

J Oral Pathol Med. 2012 Nov;41(10):728-35. doi: 10.1111/j.1600-0714.2012.01175.x. Epub 2012 May 29.

PMID:
22643047
[PubMed - indexed for MEDLINE]
13.

Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.

Yamachika S, Nanni JM, Nguyen KH, Garces L, Lowry JM, Robinson CP, Brayer J, Oxford GE, da Silveira A, Kerr M, Peck AB, Humphreys-Beher MG.

J Rheumatol. 1998 Dec;25(12):2371-80.

PMID:
9858432
[PubMed - indexed for MEDLINE]
14.
15.

Primary Sjögren's syndrome and deficiency of ICA69.

Winer S, Astsaturov I, Cheung R, Tsui H, Song A, Gaedigk R, Winer D, Sampson A, McKerlie C, Bookman A, Dosch HM.

Lancet. 2002 Oct 5;360(9339):1063-9.

PMID:
12383988
[PubMed - indexed for MEDLINE]
16.

Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in mice.

Jin JO, Kawai T, Cha S, Yu Q.

Arthritis Rheum. 2013 Aug;65(8):2132-42. doi: 10.1002/art.38007.

PMID:
23666710
[PubMed - indexed for MEDLINE]
17.

Preventive effect of Ophiopogon japonicus polysaccharides on an autoallergic mouse model for Sjogren's syndrome by regulating the Th1/Th2 cytokine imbalance.

Wang Y, Yan T, Shen J, Guo H, Xiang X.

J Ethnopharmacol. 2007 Nov 1;114(2):246-53. Epub 2007 Aug 17.

PMID:
17888600
[PubMed - indexed for MEDLINE]
18.

Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?

Humphreys-Beher MG, Yamachika S, Yamamoto H, Maeda N, Nakagawa Y, Peck AB, Robinson CP.

Eur J Morphol. 1998 Aug;36 Suppl:247-51.

PMID:
9825931
[PubMed - indexed for MEDLINE]
19.

Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease.

Khalili S, Liu Y, Kornete M, Roescher N, Kodama S, Peterson A, Piccirillo CA, Tran SD.

PLoS One. 2012;7(6):e38615. doi: 10.1371/journal.pone.0038615. Epub 2012 Jun 7.

PMID:
22685592
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Inhibition of experimental Sjögren's syndrome through immunization with HSP60 and its peptide amino acids 437-460.

Delaleu N, Madureira AC, Immervoll H, Jonsson R.

Arthritis Rheum. 2008 Aug;58(8):2318-28. doi: 10.1002/art.23656.

PMID:
18668586
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk